Product logins

Find logins to all Clarivate products below.


Heart Valve Devices – Market Insights – Japan

The Japanese heart valve device market will experience modest growth, primarily driven by the increasing adoption of THV devices. Positive clinical outcomes and the introduction of innovative products will expand the eligible patient pool, fueling sustained growth in the heart valve device market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for heart valve devices in Japan from 2019 through 2033.

Transcatheter replacement therapies will be the driving the Japanese heart valve replacement device market.

Which new TAVI devices are poised to enter the market? What impact will these newer devices have on market dynamics and market growth?

What new transcatheter replacement devices have been approved in the Japanese market? How will they impact the overall heart valve device market?

When is TMVI therapy expected to enter the Japanese market? What TMVI devices are in development?

How will MHLW reimbursement affect TAVI adoption?

How the growth in the THV device market is going to impact the surgical market?

The competitive landscape for the THV device market is evolving.

Which competitors have the most diverse portfolios in the heart valve device space?

How companies are gaining a competitive edge through mergers and acquisitions?

MHLW reimbursement revisions will affect the Japanese heart valve device market.

How has Japan’s regulatory framework changed to align with global regulatory requirements?

What is the impact of Japan’s regulatory approval process on product launches in Japan?

What other factors will affect ASP trends?

Clinical trial results play an important factor in the heart valve device market.

How are clinical studies and guidelines impacting the uptake of THV devices?

What segments have been the most impacted by clinical results?

What will be the market impact of the approval of expanded indications for TAVI?

What technologies are larger players focusing on, and how will the first-mover advantage benefit these competitors?

Table of contents


Related Medtech Insights Reports

Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…
Report
Vascular Closure Devices – Market Insights – Global
The global VCD market will grow moderately, driven primarily by increasing endovascular interventional procedure volumes and by innovation associated with new products entering the market. Growth…
Report
Varicose Vein Treatment Devices – Market Insights – United States
The US varicose vein treatment device market will be driven by the continued shift toward minimally invasive procedures and the evolving reimbursement landscape supporting endovenous ablation and…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…